In this task, you're given a paragraph from the research paper and your task is to generate a suitable title for the research paper based on the given paper. Under 100 words is a good title length.

Q: Glycyrrhetinic acid monoglucuronide (GAMG) is a great value-added and has considerable commercial interest due to its strong pharmacological activities and functional low-calorie sweetener. However GAMG is quite rare in natural plants, and it must be prepared from glycyrrhizin (GL) by hydrolysing one terminal glucuronic acid. β-Glucuronidase is the key enzyme in the biotransformation of GL to GAMG, but its activities need to be enhanced to facilitate the industrial large-scale production of GAMG. In this study, we identified that isoliquiritigenin (ISL), as one of chemical compositions from the total flavonoids glycyrrhiza (TFG), can significantly enhance β-glucuronidase activity in vitro. Measurements using high-performance liquid chromatography (HPLC) showed that the activity of β-glucuronidase could be increased by 2.66-fold via the addition of ISL to a β-glucuronidase solution that contained GL at a 3:10 molar ratio of ISL to GL. ISL was concluded to be an activator because ISL could reduce the K m and E a of β-glucuronidase reacting with GL. This study sheds new light on the mechanism of βglucuronidase and helps to make industrial production of GAMG through fermentation feasible. Published: xx xx xxxx OPEN www.nature.com/scientificreports/ 2 Scientific RepoRts | 7: 12503 |

A: Identification of isoliquiritigenin as an activator that stimulates the enzymatic production of glycyrrhetinic acid monoglucuronide OPEN
****
Q: A randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the ability of Echinacea purpurea to prevent infection with rhinovirus type 39 (RV-39). Forty-eight previously healthy adults received echinacea or placebo, 2.5 mL 3 times per day, for 7 days before and 7 days after intranasal inoculation with RV-39. Symptoms were assessed to evaluate clinical illness. Viral culture and serologic studies were performed to evaluate the presence of rhinovirus infection. A total of 92% of echinacea recipients and 95% of placebo recipients were infected. Colds developed in 58% of echinacea recipients and 82% of placebo recipients ( , by Fisher's exact test). Administration of echinacea before and after exposure to rhinovirus did not P p .114 decrease the rate of infection; however, because of the small sample size, statistical hypothesis testing had relatively poor power to detect statistically significant differences in the frequency and severity of illness. Colds are the most common acute infectious illnesses in humans. Prevention of the common cold with immunization is not practical because of the antigenic diversity of the many viruses causing colds. For example, rhinoviruses, which account for ∼40% of adult colds, have 1100 antigenic serotypes. Viruses of different and distinct families, such as coronavirus, parainfluenza virus, respiratory syncytial virus, influenza virus, adenovirus, and metapneumovirus, also cause colds. Products derived from Echinacea purpurea, the purple coneflower, are among the most popular herbal remedies in the United States. It is estimated that Americans spend more than $300 million/year on these products [1], which are commonly self-administered for the prevention and treatment of the common cold. The 3

A: Echinacea purpurea for Prevention of Experimental Rhinovirus Colds
****
Q: TiO 2 photocatalysts were prepared and coated on surfaces. Ultrathin TiO 2 coatings were obtained by wash-coating and screen-printing techniques. The latter provides films of excellent adhesion that could tolerate washing under water jet. The scratch-proof coatings were characterized, and X-ray diffraction (XRD), atomic force microscopy (AFM) and N 2 physisorption indicated that the addition of polyethylene glycol (PEG) not only improved the coating properties of TiO 2 but also served as poragen to produce high surface area, mesoporous TiO 2 . The coated TiO 2 displayed better activity than the commercial P25 TiO 2 for photocatalytic oxidation of ethylene, ethanol, acetaldehyde, isopropanol and acetone. The catalyst also exhibited excellent bactericidal, fungicidal and virucidal activities against a wide variety of Gram-positive and Gram-negative bacteria, fungal spores and T2 bacterial phage. A simple photoreactor with tangential air flow was designed and tested in a chamber, before incorporating in a prototype air purifier. The study showed that there is good agreement between laboratory catalyst reaction data (i.e., 110 mmol h −1 for acetone) and the prototype test results (69 mmol h −1 ).

A:
Investigation of the performance of TiO 2 photocatalytic coatings
****